U-Ploid Biotechnologies aims to revolutionize IVF for Age-Related Infertility. Millions of women around the world face the emotional and financial toll of age-related infertility. As more individuals choose to start families later in life, the demand for effective fertility treatments has never been higher. U-Ploid Biotechnologies is a venture-backed startup on a mission to transform […]

BioTryp Therapeutics is University of Cambridge spin-out biotechnology company that focuses on the development of small molecules to inhibit biofilm formation, which causes 80% of chronic and recurrent infections. BioTryp’s technology targets bacteria’s key defense mechanism, offering an alternative to traditional antibiotic treatments. The company’s small molecules are designed to block the communication process that […]

Bastion Therapeutics is a pre-clinical stage biotechnology company focused on developing best-in-class Treg cell therapies, which can target the root causes of inflammatory disorders and autoimmune diseases. Bastion’s GRIT™ (Genetically Reconfigured & Improved Treg) platform technology utilises genetic engineering to restore and enhance the patient’s Treg function while also targeting Tregs to specific sites of […]